SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) June 4, 2004
AXONYX INC.
(Exact name of Registrant as Specified in its Charter)
Nevada 000-25571 86-0883978
(State or Other Jurisdiction (Commission file Number) (IRS Employer
of Incorporation) Identification No.)
500 Seventh Avenue, 10th Floor, New York, New York 10018
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (212) 645-7704
Item 5. Other Events
On June 1, 2004, Axonyx Inc., which holds a controlling interest in OXIS
International, Inc. (OTCBB:OXIS) (Nouveau Marche:OXIS), loaned OXIS $1.2
million, which will be due and payable in one year or until a qualified
financing occurs (whichever is earlier). Interest on this loan accrues at 7% per
annum and is payable quarterly. This loan is partially secured by certain assets
of OXIS. The loan, in the form of a one-year secured note, will be used to
continue the advancement of OXIS' oxidative stress programs and other working
capital purposes.
Among other uses, the working capital will help to advance the OXIS Cardiac
Predictor Program. The loan proceeds also will be used to further OXIS' efforts
to bring to market OXIS' antioxidant Ergothioneine as a nutritional supplement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized on this 4th day of June, 2004.
AXONYX INC.
By: /s/ S. COLIN NEILL
--------------------------------
Name: S. Colin Neill
Title: Chief Financial Officer
2